C

CuraeLab

Europe, Ile-de-France, France, Paris

Description

French healthcare company

Investor Profile

CuraeLab has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in Iceland.
  • Strong thematic focus on Health Care, Manufacturing, Medical.

Stage Focus

  • Series C (100%)

Country Focus

  • Iceland (100%)

Industry Focus

  • Health Care
  • Manufacturing
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CuraeLab frequently co-invest with?

Alvogen
North America, New Jersey, United States, Morristown
Co-Investments: 1
Novator
Europe, England, United Kingdom, London
Co-Investments: 1
Emerson Collective
North America, California, United States, Palo Alto
Co-Investments: 1

What are some of recent deals done by CuraeLab?

Kerecis

Ísafjörður, Vestur-Isafjardarsysla, Iceland

Kerecis is a commercial stage company pioneering the use of fish skin and fatty acids in cellular-therapy and regenerative-medicine

Health CareManufacturingMedicalMedical Device
Series CJun 13, 2019
Amount Raised: $16,000,000